532437-63-1

Upstream product

• 532437-89-1 (4R,6R)-4-Methyl-2-phenyl-6-((S)-toluene-4-sulfinylmethyl)-[1,3]dioxane 
• 532437-72-2 (2R,4R,S_S)-2,4-dihydroxy-1-(p-tolylsulfinyl)pentane 
• 532437-70-0 (2R,S_S)-2-hydroxy-1-(p-tolylsulfinyl)pentan-4-one 
• 532437-74-4 (2R,4R)-4-benzyloxy-2-hydroxy-1-(mercapto-p-tolyl)pentane 
• 532437-68-6 (S)-4,4-(ethylenedioxy)-1-(p-tolylsulfinyl)pentan-2-one 
• 532437-87-9 (R)-1-(2-Methyl-[1,3]dioxolan-2-yl)-3-((S)-toluene-4-sulfinyl)-propan-2-ol 

Downstream Products

• 532437-80-2 (3S,7S,9R)-7-acetoxy-9-benzyloxy-1,3-O-cyclohexylidene-3-methyldec-4-yne 
• 532437-78-8 (3S,7S,9R)-9-benzyloxy-7-hydroxy-1,3-O-cyclohexylidene-3-methyldec-4-yne 

Relevant academic research and scientific papers

An enantioselective synthesis of the core unit of the non-nucleoside reverse transcriptase inhibitor taurospongin A

An enantioselective formal synthesis of taurospongin A has been achieved. The key steps involve chelation-controlled reductions of β-ketosulfoxide and β-hydroxy ketone intermediates and Sharpless asymmetric epoxidation to construct the tertiary alcohol st